Home Authors Posts by Sarah Pringle

Sarah Pringle

Carlyle, GTCR, Albany Molecular, private equity, merger, M&A, healthcare
Another pair of bulge-bracket sponsors are injecting capital into clinical-trial services, underscoring interest in a segment that has seen a strong flow of dealmaking in recent years. Carlyle Group and GTCR teamed up to acquire Albany Molecular Research, a global contract research and management company serving the pharma and biotech industries. The investors agreed to […]
Bain Capital Ventures, private equity, merger, M&A, healthcare, Medicare, Medicaid, Tom Price, HHS
The continued transition toward value-based care bodes well for Remedy Partners, the VC-backed company currently exploring a sale, four people familiar with the matter said. The Bain Capital Ventures-backed “episodes of care” company has turned to JPMorgan Securities for financial advice, said three of the sources. The Darien, Connecticut, company could be either a sponsor […]
TPG Capital’s bold effort to ensure a clear victory for home-health-software company Kinnser underscores the importance of buyer differentiation in today’s competitive healthcare market. Preempting what was expected to produce a robust sales process among sponsors, TPG struck a deal to buy Kinnser through Mediware Information Systems. It was only in February that TPG completed […]
Goldman Sachs has invested in California Skin Institute, the state’s largest dermatology practice, four sources told Buyouts. The investment is understood to have come from the private capital investing unit of Goldman’s Special Situation Group, said three of the sources. While the size of the investment is uncertain, Goldman’s private capital investment platform offers junior […]
The high premium commanded in the latest vision-care deal underscores private equity’s continued interest in a sector where assets of scale remain hard to come by. Varsity Healthcare Partners this week unveiled the sale of a majority stake in EyeCare Services Partners, the ophthalmic-services provider it acquired just three years earlier. The buyer is New York […]
Health Evolution Partners, the healthcare fund run by a former George W. Bush administration official, is looking to exit its investment in CenseoHealth, three sources told Buyouts. Goldman Sachs is serving as financial adviser to the provider of in-home physician-conducted health assessments, the sources said. The Dallas company generates EBITDA in the ballpark of $40 million, […]
Summit Partners, Ability Network, private equity, merger, M&A
The JP Morgan Securities-run process for Summit Partners’ Ability Network fizzled after bids failed to meet valuation expectations, three sources familiar with the matter told Buyouts. At least one offer south of $1 billion was turned down, the sources said. One of these sources and a fourth said Summit’s Ability Network had hoped to fetch […]
TPG Capital has finally maneuvered a deal to cash out of its longtime investment in IASIS Healthcare in a transaction made possible by and large by healthcare REIT Medical Property Trust. The buyer is Cerberus Capital Management’s community-based healthcare system, Steward Health Care. The deal, announced Friday, is valued north of $2 billion including assumed debt […]
ZirMed, the healthcare-IT provider backed by one of Silicon Valley’s most prominent venture firms, is about to kick off a process that could produce a billion-dollar transaction, VCJ has learned. The Sequoia Capital-backed company has turned to William Blair & Co for financial advice, according to three sources, one of whom said the process is poised to […]
ZirMed, the healthcare-IT provider backed by one of Silicon Valley’s most prominent venture firms, is about to kick off a process that could produce a billion-dollar transaction, Buyouts has learned. The Sequoia Capital-backed company has turned to William Blair & Co for financial advice, according to three sources, one of whom said the process is poised to […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination